Iron Studies and Serum Ferritin

Iron is an indispensable trace micronutrient required for essential biochemical functions across all human tissues. Approximately three to four grams of iron exist in the adult body, organized into two primary physiological compartments:

1. Functional Iron Compartment (~75%): Predominantly utilized in hemoglobin within circulating erythrocytes and erythroid precursors (~2.5 g), myoglobin in skeletal and cardiac muscle (~300–400 mg), and essential cellular metalloenzymes including mitochondrial respiratory cytochromes, catalase, and ribonucleotide reductase (~100 mg).
2. Storage and Transport Compartments (~25%): Storage iron is sequestered as soluble ferritin and insoluble hemosiderin within reticuloendothelial macrophages of the spleen, liver Kupffer cells, bone marrow, and parenchymal hepatocytes (~800–1,000 mg in adult males, ~300–500 mg in adult females). Transport iron represents a small but intensely dynamic pool (~3–4 mg) circulating bound to the bilobal plasma glycoprotein transferrin.

Humans possess no active physiological excretory pathway for excess iron; daily balance is governed entirely through the tight regulation of intestinal duodenal absorption and macrophage recycling:

• Ferroportin (FPN): The sole identified mammalian cellular iron exporter, expressed on the basolateral surface of duodenal enterocytes, hepatocyte membranes, and reticuloendothelial macrophages.
• Hepcidin: A 25-amino acid peptide hormone synthesized by hepatocytes in response to circulating transferrin saturation, hepatic iron stores, and inflammatory cytokines (predominantly Interleukin-6). Hepcidin binds to cell-surface ferroportin, inducing its phosphorylation, internalization, and lysosomal degradation.
• High Hepcidin (Systemic inflammation, iron excess): Ferroportin is degraded → iron is trapped inside duodenal enterocytes (lost when cells shed) and sequestered within reticuloendothelial macrophages → serum iron drops, producing the hallmark hypoferremia of Anemia of Chronic Disease (ACD).
• Low Hepcidin (Absolute iron deficiency, accelerated erythropoiesis): Ferroportin remains stable on cell membranes → robust duodenal iron absorption and unimpeded release from macrophage storage pools into circulation to feed erythroid marrow precursors.

A standard clinical "Iron Panel" measures serum iron, quantifies the total iron-binding capacity (or direct transferrin concentration), derives transferrin saturation (TSAT), and assays serum ferritin.

Iron parameters are exceptionally vulnerable to pre-analytic fluctuations that can lead to diagnostic errors:

• Diurnal Rhythm: Serum iron exhibits pronounced circadian rhythmicity, peaking in the morning (07:00–10:00) and declining by 30% to 50% in the late afternoon and evening. Consequently, specimens must be drawn early in the morning after an overnight fast.
• Recent Oral or IV Iron Ingestion: Ingestion of an oral iron tablet within 24 to 48 hours of blood collection produces a transient spike in serum iron that can falsely normalize TSAT in a patient with severe marrow iron depletion. Withhold oral iron supplements for at least 48 to 72 hours prior to testing. For intravenous iron formulations, serum ferritin and iron remain unreliable for 2 to 4 weeks post-infusion.
• Hemolysis Interference: Hemolysis during venipuncture (underfilled tube, vigorous shaking, narrow needle draw) releases intracellular hemoglobin and intra-erythrocytic iron into the serum, causing artifactual elevation of serum iron and false-positive TSAT calculations.
• Specimen Tube & Anticoagulant: Testing requires a standard serum separator tube (gold or red top). Lavender-top (EDTA), green-top (heparin), or grey-top (fluoride/oxalate) tubes must never be used because these anticoagulants chelate multivalent cations and interfere with colorimetric iron assay reagents.
• Recent Blood Transfusion: A single unit of packed red blood cells contains approximately 200 to 250 mg of elemental iron. Blood transfusion within the preceding 4 to 8 weeks temporarily elevates both serum ferritin and TSAT, masking pre-existing iron depletion.

• Ferritin $< 30\ \mu\text{g/L}$: Definitive cut-off for absolute iron deficiency anemia in adults with normal inflammatory markers.
• Ferritin $30\text{–}100\ \mu\text{g/L}$ in Active Inflammation: High probability of concomitant iron deficiency masked by acute-phase reactivity; confirm with TSAT < 20% or elevated soluble transferrin receptor (sTfR).
• TSAT $< 20\%$: Primary hallmark of iron-restricted erythropoiesis; used across oncology, nephrology (CKD target >20%), and cardiology (heart failure criteria: ferritin <100 or ferritin 100–299 with TSAT <20%).
• TSAT $\ge 45\text{–}50\%$: Primary screening threshold for hereditary hemochromatosis; triggers confirmatory genetic testing.
• Ferritin $> 1,000\ \mu\text{g/L}$: High risk of parenchymal tissue organ damage (hepatic cirrhosis, cardiomyopathy, endocrine failure); requires urgent specialist evaluation.

Ordering an iron profile is clinically indicated in:

1. Investigation of Anemia: Microcytic (MCV < 80 fL) or normocytic (MCV 80–100 fL) anemia.
2. Evaluation of Unexplained Systemic Symptoms: Restless legs syndrome (RLS), pica (compulsive consumption of ice, chalk, or clay), fatigue out of proportion to hemoglobin levels, koilonychia (spoon nails), or angular cheilitis.
3. Chronic Disease Monitoring:

• Chronic Kidney Disease (CKD): Screening before and during erythropoiesis-stimulating agent (ESA) therapy to prevent functional iron deficiency.
• Chronic Heart Failure: Screening in symptomatic NYHA Class II–IV patients to determine eligibility for intravenous iron supplementation.
• Inflammatory Bowel Disease (IBD): High prevalence of mucosal malabsorption and chronic occult bleeding.

1. Suspected Iron Overload: Family history of hereditary hemochromatosis, unexplained elevated transaminases, bronze skin hyperpigmentation, diabetes mellitus with hepatomegaly ("bronze diabetes"), chondrocalcinosis, or in patients requiring chronic lifetime transfusions (thalassemia major, sickle cell disease, myelodysplastic syndromes).
2. Monitoring Oral or IV Iron Replenishment: Confirming restoration of body stores.

┌─────────────────────────────────────────────────────────────┐
│          STEP-BY-STEP IRON PANEL INTERPRETATION             │
├─────────────────────────────────────────────────────────────┤
│ Step 1: Examine Serum Ferritin                              │
│         ├─ Ferritin < 30 ug/L: Absolute Iron Deficiency     │
│         ├─ Ferritin 30 - 100 ug/L: Indeterminate; check     │
│         │  inflammatory markers (CRP, ESR) and TSAT         │
│         ├─ Ferritin 100 - 300 ug/L: Normal stores or ACD    │
│         └─ Ferritin > 500 - 1000 ug/L: Severe hyper-        │
│            ferritinemia (Overload vs Inflammation/MASH)     │
├─────────────────────────────────────────────────────────────┤
│ Step 2: Calculate Transferrin Saturation (TSAT)             │
│         TSAT = (Serum Iron / TIBC) x 100                    │
│         ├─ TSAT < 15 - 20%: Iron-restricted supply          │
│         ├─ TSAT 20 - 45%: Normal iron transport             │
│         └─ TSAT > 45 - 50%: Iron overload state             │
├─────────────────────────────────────────────────────────────┤
│ Step 3: Compare Ferritin with TIBC Pattern                  │
│         ├─ Low Ferritin + High TIBC (> 70 umol/L): Classic  │
│         │  Iron Deficiency Anemia (IDA)                     │
│         ├─ High Ferritin + Low TIBC (< 45 umol/L): Classic  │
│         │  Anemia of Chronic Disease (ACD)                  │
│         └─ Normal/High Ferritin + Normal/Low TIBC +         │
│            TSAT < 20%: Mixed IDA + ACD                      │
├─────────────────────────────────────────────────────────────┤
│ Step 4: Adjudicate Equivocal Profiles with Advanced Markers │
│         ├─ Soluble Transferrin Receptor (sTfR): Elevated    │
│         │  in true IDA; normal in pure ACD                  │
│         └─ sTfR / log10(Ferritin) Index: > 2 confirms IDA  │
├─────────────────────────────────────────────────────────────┤
│ Step 5: Clinical Source Investigation (Mandatory)           │
│         If IDA confirmed in adult male or postmenopausal    │
│         female: Proceed directly to GI endoscopy            │
│         (OGD + Colonoscopy) to rule out occult malignancy.  │
└─────────────────────────────────────────────────────────────┘

• Absolute Iron Deficiency: Depletion of total body stores (exhausted bone marrow and liver iron). Always accompanied by low serum ferritin (<30 µg/L) unless masked by profound active tissue infection or inflammation.
• Functional Iron Deficiency (Iron-Restricted Erythropoiesis): Total body iron stores are normal or elevated, but iron is locked inside reticuloendothelial macrophages by hepcidin-mediated ferroportin degradation. The erythroid marrow is starved of iron despite ample storage. Marked by low serum iron, low TSAT (<20%), normal/high ferritin, and lack of response to standard oral iron therapy. Intravenous iron bypasses the hepcidin block.

• Recent Intravenous Iron Infusions: Formulations such as ferric carboxymaltose, ferumoxytol, or iron sucrose interfere directly with laboratory photometers and falsely elevate serum ferritin into the thousands for 2 to 4 weeks post-treatment. Retest only after a 4-week washout period.
• Oral Contraceptive Pills and Pregnancy: Estrogens stimulate hepatic synthesis of apotransferrin, raising TIBC and lowering baseline TSAT in the absence of true tissue iron deficit.
• Corticosteroid Therapy: Suppresses acute-phase protein expression and lowers serum ferritin levels while transiently elevating serum iron.
• Biotin Supplementation: Immunoassays utilizing streptavidin-biotin technology can produce spurious ferritin measurements (false highs or false lows depending on competitive vs sandwich assay architecture). Discontinue high-dose biotin 48 hours prior to sampling.

1. The "Ferritin Acute-Phase Trap": Because ferritin synthesis is driven by IL-6, a "normal" ferritin of 60 to 80 µg/L in a patient with rheumatoid arthritis, active ulcerative colitis, end-stage kidney disease, or metastatic cancer does NOT exclude severe iron deficiency. In such patients, rely on TSAT < 20% or sTfR.
2. The "Serum Iron Fluctuation Fallacy": Measuring serum iron without TIBC and ferritin is clinically useless. A low serum iron alone simply reflects that iron has not entered circulation in the last few hours (due to circadian trough, a missed meal, or acute mild inflammation).
3. Misdiagnosis of Hyperferritinemia as Hemochromatosis: Over 90% of elevated ferritin results in outpatient clinical practice are caused by:

• Chronic alcohol excess (toxic induction of hepatic ferritin release).
• Metabolic dysfunction-associated steatotic liver disease (MASLD / MASH).
• Acute infection, hepatitis, or occult lymphoma.
• Adult-Onset Still's Disease (extreme ferritin often > 10,000 µg/L).

Check Transferrin Saturation first: If TSAT is < 45%, genetic hemochromatosis is exceedingly unlikely.

• The Mentzer Index Re-visited: In microcytic anemia (MCV < 80 fL), calculate MCV / RBC count. If > 13 → order iron studies (likely iron deficiency); if < 13 → order hemoglobin electrophoresis (likely thalassemia trait).
• The Soluble Transferrin Receptor (sTfR) Gold Standard: When ferritin is uninterpretable due to inflammation, sTfR breaks the deadlock. Why? sTfR expression is regulated solely by cellular iron need and erythroid activity; it is completely unaffected by systemic inflammation. High sTfR = Iron deficiency. Normal sTfR = Pure anemia of chronic disease.
• The "Bronze Diabetes" Triad: Hyperpigmentation ("bronze" skin due to melanin and hemosiderin deposition), diabetes mellitus (pancreatic islet beta-cell siderosis), and cirrhosis = classic triad of advanced hereditary hemochromatosis.
• Restless Legs Syndrome (RLS) Threshold: In patients with idiopathic RLS, target serum ferritin should be maintained > 75 µg/L (rather than the general laboratory lower limit of 30 µg/L) to optimize cerebral dopaminergic transmission.

• Complete Blood Count (CBC) and Indices: Documents microcytic hypochromic anemia and high RDW (Complete Blood Count).
• Peripheral Blood Film (PBF): Confirms anisocytosis, poikilocytosis, and pencil-shaped elliptocytes (Peripheral Blood Film).
• Inflammatory Markers (CRP, ESR): Adjudicates whether high ferritin is acute-phase reactivity (Inflammatory Markers).
• HFE Gene Mutation Analysis: Confirms C282Y homozygosity in suspected hereditary hemochromatosis with TSAT > 45–50%.
• Endoscopic Triage (OGD & Colonoscopy): Gold standard diagnostic investigation to locate the etiology of iron loss in adult patients with IDA.